Genetic Control of Human Infection with SARS-CoV-2

Area of Science:

• Genetics and Virology
• Infectious Diseases

Background:

• Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) caused the COVID-19 pandemic.
• Host genetic factors and viral characteristics significantly impact SARS-CoV-2 susceptibility and disease course.
• SARS-CoV-2 shares genomic similarities with SARS-CoV and MERS-CoV, but possesses unique features, notably in its S protein.

Purpose of the Study:

• To explore the genetic underpinnings of SARS-CoV-2 susceptibility and COVID-19 clinical presentation.
• To identify key human genes and viral factors involved in SARS-CoV-2 infection and replication.
• To understand how genetic variations and population-level differences influence COVID-19 prevalence and severity.

Main Methods:

• Comparative genomic analysis of SARS-CoV-2 against other coronaviruses.
• Identification and characterization of human genes encoding receptors, proteases, and antiviral proteins involved in viral entry and replication.
• Review of genetic variants within these human genes and their functional significance.

Main Results:

• SARS-CoV-2 exhibits unique S protein features, including a furin cleavage site absent in related coronaviruses, potentially explaining its high pathogenicity.
• Key human genes (e.g., ACE2, TMPRSS2, FURIN, IFITM proteins) are crucial for SARS-CoV-2 binding, entry, and replication.
• Genetic variations in these host genes, with differing allele frequencies across global populations, may explain interpopulation disparities in COVID-19 outcomes.

Conclusions:

• Human genetic makeup plays a critical role in determining susceptibility and clinical trajectory of COVID-19.
• Specific genetic variants and their population-level distribution are important factors in understanding global COVID-19 epidemiology.
• Epigenetic modifications, comorbidities, medications, and lifestyle factors can further modulate the expression of infection-related genes.